Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Market Closed - Euronext Paris
Other stock markets
 11:35:02 2024-05-03 EDT 		5-day change 1st Jan Change
2.875 EUR -1.54% Intraday chart for PHAXIAM Therapeutics S.A. -2.54% -37.50%
04-15 Phaxiam initiates trial in infective endocarditis CF
04-15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.34B -
GENMAB A/S Stock Genmab A/S
 19.25B
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. PHXM Stock
  5. Charts PHAXIAM Therapeutics S.A.
  6. Sector Chart